Metraipolis › archive › dc_236258c13618

Combining Temozolomide with a Selective CK2 Inhibitor Results in Anti-Tumour Effects in Glioblastoma Cell Lines — Europe PMC PMID:41828892

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41828892
DOI
10.3390/molecules31050907
License (as archived)
solo-consultazione
Archived
2026-11-05T00:29:01.783Z
SHA-256 of the archived text
3f7491f7db8b8cc5bc2b91826d33815961ff84f1c0451b1e509c5528969c84cf
Stable URL of this page
https://metraipolis.com/documento/dc_236258c13618

How to cite

Combining Temozolomide with a Selective CK2 Inhibitor Results in Anti-Tumour Effects in Glioblastoma Cell Lines — Europe PMC PMID:41828892 — Europe PMC (en), https://europepmc.org/article/MED/41828892 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_236258c13618 (Metraipolis archive dc_236258c13618, sha256 3f7491f7db8b8cc5bc2b91826d33815961ff84f1c0451b1e509c5528969c84cf)
BibTeX
@misc{dc236258c13618,
  title = {Combining Temozolomide with a Selective CK2 Inhibitor Results in Anti-Tumour Effects in Glioblastoma Cell Lines — Europe PMC PMID:41828892},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41828892},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_236258c13618; sha256 3f7491f7db8b8cc5bc2b91826d33815961ff84f1c0451b1e509c5528969c84cf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41828892. Agents can read the archived copy with the MCP tool read_document.